- Home
- ZNTL vs RFI Comparison
ZNTL vs RFI Comparison
Compare ZNTL & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- RFI
- Stock Information
- Founded
- ZNTL 2014
- RFI 1992
- Country
- ZNTL United States
- RFI United States
- Employees
- ZNTL N/A
- RFI N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- RFI Investment Managers
- Sector
- ZNTL Health Care
- RFI Finance
- Exchange
- ZNTL Nasdaq
- RFI Nasdaq
- Market Cap
- ZNTL 105.8M
- RFI 323.2M
- IPO Year
- ZNTL 2020
- RFI N/A
- Fundamental
- Price
- ZNTL $1.33
- RFI $11.90
- Analyst Decision
- ZNTL Buy
- RFI
- Analyst Count
- ZNTL 7
- RFI 0
- Target Price
- ZNTL $8.60
- RFI N/A
- AVG Volume (30 Days)
- ZNTL 1.4M
- RFI 69.8K
- Earning Date
- ZNTL 08-08-2025
- RFI 01-01-0001
- Dividend Yield
- ZNTL N/A
- RFI 8.25%
- EPS Growth
- ZNTL N/A
- RFI N/A
- EPS
- ZNTL N/A
- RFI N/A
- Revenue
- ZNTL $26,865,000.00
- RFI N/A
- Revenue This Year
- ZNTL N/A
- RFI N/A
- Revenue Next Year
- ZNTL N/A
- RFI N/A
- P/E Ratio
- ZNTL N/A
- RFI N/A
- Revenue Growth
- ZNTL N/A
- RFI N/A
- 52 Week Low
- ZNTL $1.01
- RFI $9.62
- 52 Week High
- ZNTL $5.44
- RFI $12.52
- Technical
- Relative Strength Index (RSI)
- ZNTL 50.91
- RFI 46.23
- Support Level
- ZNTL $1.15
- RFI $11.85
- Resistance Level
- ZNTL $1.38
- RFI $12.18
- Average True Range (ATR)
- ZNTL 0.10
- RFI 0.13
- MACD
- ZNTL 0.01
- RFI -0.02
- Stochastic Oscillator
- ZNTL 75.00
- RFI 34.88
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.